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Background. Strategies to prevent Staphylococcus aureus infection in hospitals focus on patient-to-patient
transmission. We used whole-genome sequencing to investigate the role of colonized patients as the source of new
S. aureus acquisitions, and the reliability of identifying patient-to-patient transmission using the conventional ap-
proach of spa typing and overlapping patient stay.
Methods. Over 14 months, all unselected patients admitted to an adult intensive care unit (ICU) were serially
screened for S. aureus. All available isolates (n = 275) were spa typed and underwent whole-genome sequencing to
investigate their relatedness at high resolution.
Results. Staphylococcus aureus was carried by 185 of 1109 patients sampled within 24 hours of ICU admission
(16.7%); 59 (5.3%) patients carried methicillin-resistant S. aureus (MRSA). Forty-four S. aureus (22 MRSA) acquisi-
tions while on ICU were detected. Isolates were available for genetic analysis from 37 acquisitions. Whole-genome
sequencing indicated that 7 of these 37 (18.9%) were transmissions from other colonized patients. Conventional
methods (spa typing combined with overlapping patient stay) falsely identiﬁed 3 patient-to-patient transmissions
(all MRSA) and failed to detect 2 acquisitions and 4 transmissions (2 MRSA).
Conclusions. Only a minority of S. aureus acquisitions can be explained by patient-to-patient transmission.
Whole-genome sequencing provides the resolution to disprove transmission events indicated by conventional
methods and also to reveal otherwise unsuspected transmission events. Whole-genome sequencing should replace
conventional methods for detection of nosocomial S. aureus transmission.
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Staphylococcus aureus is a leading cause of healthcare-
associated infection. Carriage usually precedes infection,
and the risk of invasive disease is greatest immediately
after acquisition of a new strain [1, 2]. Efforts to reduce
S. aureus infections focus on preventing patient-to-
patient transmission, including measures that target
methicillin-resistant S. aureus (MRSA) such as screen-
ing and decolonization. In England, MRSA screening
has been mandatory since 2006. Although MRSA
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bacteremia rates have fallen, rates of methicillin-sensitive S.
aureus (MSSA) bacteremia remain high [3].
Staphylococcus aureus population structure is dominated by a
few prevalent clones that account for most infections [4]. Strains
of clonal complex (CC) 22 and 30 account for >95% of UK hospi-
tal MRSA cases. Conventional typing techniques lack the resolu-
tion necessary to differentiate closely related strains [5]. Reference
laboratories commonly employ spa typing which has comparable
resolution to multilocus sequence typing (MLST) and is more
portable than pulsed-ﬁeld gel electrophoresis (PFGE) [6, 7]. Al-
though different spa types are usually genetically distant, a single
base-pair change within the spa gene can produce 2 different but
highly related spa types [8].
Staphylococcus aureus evolves primarily through point muta-
tion, accumulating single-nucleotide variants (SNVs) over time
[9]. Estimated mutation rates vary between 2.0 and 3.4 × 10−6
mutations per site per year [10–13]. This equates to 5.6–9.5
mutations per year over the whole genome or approximately 1
SNV difference every 5–10 weeks. Consequently, whole-genome
sequencing reveals the genetic relatedness of isolates at far
greater resolution than conventional techniques and implies a
temporal relationship between isolates [14–17]. Costs and pro-
cessing times will soon match those of conventional methods.
Here we report the ﬁrst systematic evaluation of nosocomial
patient-to-patient transmission of S. aureus using whole-
genome sequencing. We analyzed weekly screening samples
from all patients admitted to an adult intensive care unit (ICU).
Staphylococcus aureus colonization status was determined by
sampling on admission to ICU, followed by weekly sampling to
detect acquisition. Patient-stay data and spa typing were used to
identify acquisitions that could be attributed to patient-to-
patient transmission using conventional typing and epidemiolo-
gy. Whole-genome sequencing was then applied to assess the
validity of conventional methods and determine more accurate-
ly the role of patients as sources of S. aureus in the ICU.
METHODS
Setting and Patients
The study was conducted on a 16-bed, adult ICU between
1 January 2010 and 28 February 2011 (14 months) in an acute
teaching hospital (Brighton and Sussex University Hospitals)
on the south coast of England. Routine practice was to screen
all patients at admission and weekly thereafter. Screens con-
sisted of nasal and perineal swabs plus additional samples
for some patients from groin, sputum, urine, and wounds.
FromMay 2010, patients were also screened at time of discharge.
All patients received chlorhexidine washes, and MRSA-posi-
tive patients received nasal mupirocin. Anonymized demo-
graphic details and hospital stay data were collected from
patient records.
Deﬁnitions of Acquisition and Patient-to-Patient Transmission of
S. aureus
Staphylococcus aureus acquisition was deﬁned by a negative ad-
mission screen followed by a later positive screen; or a positive
admission screen followed by later culture of a genetically dif-
ferent strain.
Patient-to-patient transmission on ICU was deﬁned accord-
ing to conventional criteria by acquisition of S. aureus with
matching spa type and methicillin susceptibility of a strain cul-
tured previously from a colonized patient with overlapping
ICU stay; by whole-genome sequencing using SNV differences
(irrespective of overlapping patient stay, to allow for indirect
transmission via the environment or a vector), with a SNV dif-
ference of >40 used to exclude recent transmission [18].
Microbiology
Swabs were plated directly onto chromogenic MRSAselect
(Bio-Rad, Redmond, Washington) and Columbia CNA (Oxoid
Ltd, Basingstoke, UK) agar. Plates were incubated at 35°C –37°C
in air for 18 hours. Identiﬁcation was conﬁrmed with PROLEX
Staph Xtra Latex Kit (Pro-Lab Diagnostics, Cheshire, UK) plus
either RapiDEC-Staph (bioMérieux, Hampshire, UK) or Mi-
croﬂex series MALDI-TOF (Bruker Daltonics). Antibiotic sus-
ceptibilities were determined by disk diffusion [19]. Isolates
were stored on ambient slopes and then transferred to Matrix 2D
Barcoded Storage Tubes (ThermoFisher Scientiﬁc, Cheshire,
UK) and stored at −80°C.
Spa Typing
Spa typing was performed as described previously [20]. In
brief, the X region of the spa gene was ampliﬁed by polymerase
chain reaction (PCR) with primers 1095F (5′-AGACGATCC
TTCGGTGAGC-3′) and 1517R (5′-GCTTTTGCAATGTC
ATTTACTG-3′) (Invitrogen), and PCR products were puriﬁed
using Agencourt AMPure XP beads (Beckman Coulter,
London, UK). Following sequencing, products were puriﬁed
using Agencourt CleanSEQ beads (Beckman Coulter, London,
UK). Sequencing was performed on an ABI 3730 DNA Analyz-
er (Applied Biosystems). The spa types were determined using
Ridom StaphType (Ridom GmbH, Germany).
Whole-Genome Sequencing
Cultures were incubated overnight on individual Columbia
Blood Agar (Oxoid, Basingstoke, UK). DNAwas puriﬁed from a
5-µL loop sweep of culture growth using QuickGene DNA tissue
kits (Autogen) according to the manufacturer’s instructions.
Whole-genome sequencing was performed on the Illumina
HiSeq2000 using previously described protocols for bacterial
library preparation and bioinformatics processing [14] in which
SNVs in mapped nonrepetitive sites were identiﬁed by mapping
to a CC30-speciﬁc reference (MRSA252 [21]). A minimum of at
least 5 reads, with at least 1 in each direction, and a consensus
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of >75% were required to call a SNV, which was required to be
homozygous under a diploid model. Across the sequenced
genomes, a mean of 87% of the MRSA252 reference genome
was called, and 95% of all reads generated mapped to the refer-
ence at a mean read depth of 126 (SD, 20). Maximum likeli-
hood trees were estimated from mapped whole genomes using
PhyML [22] under a Jukes-Cantor model.
Sequencing data were used to measure genomic diversity
within and between hosts. To assess the diversity present
within individuals over time and within sites, we measured the
maximum pairwise genetic differences between isolates ob-
tained from the same individual from the same site (eg, nose or
groin) over time and between sites at the same time excluding
acquisition isolates. To assess diversity between individuals, we
measured the minimum pairwise genetic diversity between iso-
lates obtained within 24 hours of admission to the ICU and
any previous admission isolate.
Ethics
This study was part of the Modernising Medical Microbiology
consortium “Integrating Strain Typing and Database Technolo-
gies in Research Service” approved by the Berkshire Research
Ethics Committee (reference 10/H0505/83) and the National
Information Governance Board Ethics and Conﬁdentiality
Committee (reference ECC 8–05 (e)/2010).
RESULTS
We investigated 1181 ICU patient stays involving 1065 patients.
Median age at admission was 64 years (interquartile range
[IQR], 49–76 years), 688 (59%) patients were male, and the
median length of ICU stay was 2.6 days (IQR, 1.0–5.6 days).
Carriage of S. aureus at ICU Admission
A ﬁrst screen for S. aureus carriage was conducted within 24
hours of admission to ICU in 1109 patients (93.9% of admis-
sions). A total of 1104 (99.5%) had both nasal and extranasal
swabs taken. One hundred eighty-ﬁve patients (16.7%) yielded
S. aureus, and 59 (5.3%) MRSA (Figure 1). A further 27 patients
had a ﬁrst screen performed >24 hours after ICU admission.
Staphylococcus aureus Acquisition on ICU
Six hundred eighty patients had ≥2 samples taken to assess
S. aureus carriage during their ICU stay (Figure 1). These iden-
tiﬁed 44 acquisitions, 22 of which were MRSA, in 41 patients as
follows (Figure 2): 33 patients who were negative for S. aureus
carriage on a ﬁrst screen yielded S. aureus from a later screen (1
of these subsequently acquired 2 new spa types sequentially;
hence, 35 acquisitions in this group). Additionally, 6 patients
acquired new spa types (1 patient acquired 2 new spa types se-
quentially; hence, 7 acquisitions in this group). Furthermore, 2
acquisitions were detected solely by whole-genome sequencing.
One patient, colonized with MRSA t032 at admission, acquired
a genetically distinct isolate (222 SNVs) of the same spa type 2
days later. Another patient colonized with spa type t012 at ad-
mission subsequently acquired a genetically highly distinct
(41 518 SNVs) strain. Routine spa typing had assigned this
isolate to t012; whole-genome sequencing revealed that it actu-
ally belonged to a different lineage.
Staphylococcus aureus Diversity Assessed by spa Typing
Including all samples from all patients, S. aureus was cultured
from 329 samples. Isolates from 53 samples could not be
retrieved from storage, and 1 failed spa typing (and whole-
genome sequencing) leaving 275 isolates (Supplementary Table).
Three spa types (t032 corresponding to CC22 [38.2%], t018 cor-
responding to CC30 [19.1%], and t012 corresponding to CC30
[10.3%]) accounted for 67.6% of all MRSA isolates. MSSA iso-
lates were more diverse, with only 2 (t084 [6.8%] and t012
[5.8%]) comprising >5% of the total (Supplementary Figure 1).
Staphylococcus aureus Transmission as Indicated by spa Typing
and Overlapping Patient Stay
Seven acquisition isolates could not be retrieved for typing,
leaving 37 of 44 evaluable acquisition events. Of these, 5 (14%) met
conventional criteria for patient-to-patient transmission deﬁned by
overlapping stay with a patient carrying the same spa type. All 5 in-
volved MRSA strains (Figure 2): patient number 37 (MRSA t018),
patient number 36 (MRSA t012), and patient numbers 19, 35, and
38 (MRSA t032). All 3 t032 acquisitions occurred within 3 weeks
of each other, suggesting a possible outbreak. Two other patients
on the ICU at this time were found to carry MRSA t032; 1 was
patient number 41, who acquired the strain 2 days before patient
35; the other was culture positive on primary screening and hence
a possible donor to patients 19 and 38.
Staphylococcus aureus Diversity Assessed by Whole-Genome
Sequencing
Among 275 analyzed whole genomes, the diversity seen within
and between hosts was markedly different (Figure 3). Within-
host diversity, excluding acquisition isolates, was minimal
either over time or between nasal and extranasal samples.
Among 48 evaluable isolates (32 available to assess diversity
over time and 16 to assess between-site diversity), 44 were
within 4 SNVs of the most distant within-host isolate and all
were within 40 SNVs, the maximum within-host diversity ob-
served by Golubchik et al [18].
Among 160 admission isolates of S. aureus for which
between-host diversity could be determined, 143 were >100
SNVs distant from the most similar isolate carried by another
patient, and for 154 of 160 the minimum SNV difference was
>40. Four admission isolates were highly related (<4 SNVs),
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suggesting a recent common source of acquisition; these pa-
tients originated from different clinical settings.
Evaluable acquisition isolates (n = 37) showed a bimodal
distribution of minimum SNV differences compared to other
S. aureus isolates sequenced, with 26 of 37 being >100 SNVs
from the most closely related isolate sequenced in the study,
7 being <40 SNVs, and 5 being <4 SNVs.
Transmission of S. aureus Assessed by Whole-Genome
Sequencing
Whole-genome sequencing data allowed us to scrutinize the 5
instances of patient-to-patient transmission indicated by
common spa type plus overlapping patient stay. The MRSA
t018 isolate from patient 37 was genetically indistinguishable (0
SNVs) from the putative donor, conﬁrming patient-to-patient
transmission. The MRSA t012 isolate from patient 36 differed
by 1100 SNVs from the putative donor isolate, disproving
patient-to-patient transmission. However, the most closely
related isolate was an MRSA t018 carried by a patient on the
unit at the same time that differed by 18 SNVs. The “outbreak”
identiﬁed by conventional criteria, in which patients 19, 35, 38,
and 41 acquired MRSA t032, is illustrated in Figure 4A showing
the ICU stays of all 17 patients from whomMRSA t032 was iso-
lated in the study period (assigned letters A–Q). MRSA t032
isolates in the “outbreak” period from patients J and L/19 were
highly related (2 SNVs), conﬁrming patient-to-patient trans-
mission, whereas isolates from the other 3 acquisitions (pa-
tients H/35, I/41, and K/38) were genetically distinct both from
potential donors (J; 102–354 SNVs) and from each other (102–
337 SNVs), disproving transmission.
Figure 1. Sampling of patients involved in the study. Including nasal and extranasal samples and serial samples, Staphylococcus aureus was isolated
329 times as follows: 206 isolates (*), 8 isolates (†), 115 isolates (‡). Includes 1 patient who changed strains twice (§) and 1 patient who experienced 2
strain changes after acquiring S. aureus (¶). Abbreviations: ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus.
612 • CID 2014:58 (1 March) • Price et al
Figure 2. Sampling histories of 41 patients who acquired Staphylococcus aureus. Patient 33 experienced 3 separate acquisition events, and patient 35
experienced 2 acquisitions. *Routine spa typing assigned this isolate to t012, but whole-genome sequencing (WGS) revealed that it actually belongs to a
different lineage. Patient-to-patient transmissions are identiﬁed as transmissions identiﬁed using WGS (†) and transmissions indicated by conventional cri-
teria (‡; spa typing and overlapping stay). Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus
aureus; WGS, whole-genome sequencing.
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Whole-Genome Sequencing Reveals S. aureus Transmission
Undetected by Conventional Methods
Two patients acquired MRSA t032 during the study period
without sharing time on the ICU with any other patient known
to be carrying this strain. These are patients 25 and 30 (patients
P and Q) in Figure 4A. Analysis of the genetic relatedness of all
MRSA t032 study isolates (Figure 4B) demonstrated that
whereas patient P/25’s isolate was 96 SNVs different from its
nearest neighbor, the isolate from patient Q/30 was genetically
indistinguishable (0 SNVs) from that carried by patient M, who
was discharged 7 weeks earlier.
There were 2 other instances where patients acquired strains
that were genetically indistinguishable (0 SNVs) from isolates
identiﬁed earlier on the ICU despite the patient admissions
being 18 and 34 days apart: 1 involved MRSA t008 (patient 39),
the other MSSA t024 (patient 6), respectively.
One further acquisition involved highly related pairs of iso-
lates. The MSSA t230 strain from patient 32 differed by 9 SNVs
from an isolate of the same spa type colonizing a patient dis-
charged from the ICU 107 days previously.
In total, whole-genome sequencing discounted 3 MRSA trans-
missions indicated by conventional criteria, conﬁrmed 2 trans-
missions, and identiﬁed 5 additional transmissions (3 MRSA, 2
MSSA). These comprised 4 where isolates were genetically indis-
tinguishable (3 with 0 SNVs) or closely related (9 SNVs) despite
patients not having shared time on the ICU and 1 where spa
types were discrepant despite isolates only differing by 18
SNVs and patients having shared time on the ICU.
DISCUSSION
We undertook a systematic evaluation of nosocomial patient-
to-patient transmission of S. aureus in an endemic setting in an
unselected population of consecutive patients admitted to a
typical ICU using whole-genome sequencing. Previous studies
have demonstrated the value of whole-genome sequencing for
investigation of S. aureus outbreaks [16, 17].
Among 680 patient stays evaluated with repeat sampling, we
identiﬁed only 44 acquisitions, indicating that acquisition is un-
common among ICU patients at our hospital. We did not set out
Figure 3. Staphylococcus aureus diversity shown by pairwise genetic distances in single-nucleotide variants: maximum diversity within individual pa-
tients over time and between nasal and extranasal sites; minimum diversity between different patients (for isolates cultured within 24 hours of intensive
care unit admission); minimum diversity between new acquisitions and isolates cultured within 24 hours of admission. Each dot represents a pair of iso-
lates and is shaded according to whether the pair has concordant ( ) or discordant spa types ( ).
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to study routes of acquisition prior to ICU admission, but it is note-
worthy that among S. aureus isolates obtained within 24 hours of
admission to ICU, a few were genetically highly related, suggesting
acquisition from a common source prior to ICU admission.
Previous studies have measured S. aureus mutation rates at
5–10 SNVs per year [10–13], but to avoid underestimating the
frequency of patient-to-patient transmission, we used a limit of
>40 SNV differences to exclude recent transmission, given that
SNV differences of up to 40 may be detected within an individ-
ual [18]. The observed within-host diversity indicates that this
was a reasonable assumption, as all 7 acquisition isolates were
<20 SNVs apart, 5 being <4 SNVs; only 1 acquisition isolate
had the closest other isolate just outside the 40 SNV threshold.
Conventional investigations of transmission combine epidemi-
ological information with typing of isolates. We show that use of a
conventional approach to investigate transmission (spa typing and
epidemiological association) falsely suggests transmission links
between patients but also fails to identify transmission links, par-
ticularly where patient stays do not overlap, and that transmission
might have occurred indirectly such as via healthcare workers
or environmental contamination.
Efforts to prevent patient-to-patient transmission of S. aureus
include measures such as hand hygiene and use of antiseptics,
which target all S. aureus, plus measures such as MRSA screen-
ing and decolonization, which target MRSA [23, 24]. Rates of in-
vasive MRSA infection have declined markedly in the United
Kingdom, whereas rates of invasive MSSA infection have not.
Although only a minority of S. aureus strains detected at admis-
sion to the ICU were MRSA, MRSA accounted for 50% of ac-
quisitions and 5 of 7 patient-to-patient transmissions identiﬁed
by whole-genome sequencing. These data suggest more frequent
nosocomial transmission of MRSA. Patients were the source
Figure 4. A, Intensive care unit stays of all 17 patients from whom methicillin-resistant Staphylococcus aureus (MRSA) t032 was isolated. Patients are
labeled A–Q. The numbers 35, 41, 38, and 19 correspond with patients shown in Figure 2. The red box highlights a putative “outbreak” suggested by con-
ventional criteria (same spa type plus overlapping stay). B, Maximum likelihood tree representing the genetic relatedness of MRSA t032 isolates in patients
A–Q. The branch length reﬂects single-nucleotide variants (SNVs) identiﬁed between isolates (annotated). Nodes have been colored according to isolate
type (red = acquisition isolate, yellow = carriage isolates, black = hypothetical node). Isolates sharing circles are genetically indistinguishable and touching
nodes differ by 1 SNV. Twenty-six isolates were available from 17 patients, including 2 genetically distinct isolates from patient I (I1 and I2), 2 isolates
from 7 patients (*), and 4 isolates from 1 patient (†). Abbreviation: ICU, intensive care unit.
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of only a minority of acquisitions, irrespective of methicillin
susceptibility.
Our study has some limitations. It was performed in a single
center and in the United Kingdom, a country with little reported
community-based MRSA transmission; however, our ﬁndings
should be generally applicable to ICUs where similar infection
control measures are in place. Our analysis is based on carriage,
not disease, isolates. Although patients with clinically signiﬁcant
Figure 4 Continued.
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S. aureus infections typically carry the same strain [2], it is pos-
sible that we missed some patient sources. We did not screen
for throat or rectal carriage [25]. A proportion of isolates could
not be retrieved for genetic analysis. This occurred throughout
the study and is unlikely to have distorted our results. Our
ﬁnding of related isolates in patients who did not share time on
the ICU suggests that some acquisitions may have occurred
outside the unit. Low-level S. aureus carriage may not be de-
tected. Although 99.5% of our patients were sampled from ≥2
sites, our ﬁgure of 16.7% may underestimate the frequency of
carriage at ICU admission. Previous studies report rates
between 14% and 53% among hospitalized patients [26, 27],
with higher rates (18%–46%) in high-dependency settings [28].
Although more sensitive sampling methods might have detect-
ed higher rates of carriage, it is likely that our patients were
subject to more antistaphylococcal decolonization measures
than patients recruited to these studies. Underestimation of S.
aureus carriage on ICU would be expected to result in overesti-
mation of the rate of S. aureus acquisition. However, the rate of
acquisition we have observed is relatively low. Bloemendaal
et al reported an acquisition rate of 14.2% in a study of 6 Euro-
pean ICUs [28]. Our fundamental observation, that only 18.9%
of acquisitions can be attributed to transmission from other pa-
tients, cannot be explained by low sensitivity of the sampling
method unless patients with false-negative screening results
make a disproportionately high contribution to transmission.
This seems unlikely.
A major strength of our study is that 94% of patients were
sampled within 24 hours of admission, 99.5% of these at 2 sites,
providing conﬁdence in our conclusion that patients are not
the major source of S. aureus acquisition in the ICU. Before the
introduction of enhanced hand hygiene and universal antisep-
tic use, patient-to-patient transmission of S. aureus may have
been more common. Our ﬁndings do not undermine the im-
portance of current infection control practices; rather, they
support their efﬁcacy. They indicate that whole-genome se-
quencing can be used to assess the efﬁcacy of infection control
measures to prevent S. aureus transmission. Studies to evaluate
other nosocomial sources of S. aureus (eg, the environment,
healthcare workers, visitors, the food chain) are challenging.
Substantial sample sets and clinical data and analysis would be
required. Healthcare workers and hospital managers are
anxious about identifying staff as potential sources of S. aureus.
Nevertheless, our ﬁndings demonstrate that such studies are re-
quired and emphasize the value of whole-genome sequencing.
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